NATUREX : Half year summary of the liquidity contract


Pursuant to the liquidity contract granted to NATIXIS the following elements were in the liquidity account as of December 31st, 2010:

5,632 NATUREX shares 103,376.35 euros

For information, the following elements appeared on the liquidity account as of June 30, 2010:

7,578 NATUREX shares 86,070.99 euros

Download our press releases and other publications on

Naturex is listed on NYSE Euronext Paris since October 1996 - Compartment B.

Number of shares forming the capital: 6,410,931 4,959,935 ordinary shares (ISIN FR0000054694) 1,450,996 preferred shares (ISIN FR0000010833251) Naturex is a component stock of the following indices: SBF250, CAC All Shares, CAC Mid&Small 190, CAC Small 90, Gaïa Index

ISIN: FR0000054694 (NRX) - Reuters: NATU.PA - Bloomberg: NRX:FP

About Naturex

Naturex is the world leader in specialty plant-based natural ingredients.

The Group, organized around three strategic markets - Food&Beverage, Nutrition&Health and Personal Care - , manufactures and markets natural ingredients for food, nutraceutical, pharmaceutical and cosmetic industries.

Naturex, whose head office is based in Avignon (France), employs more than 950 persons and benefits from high performance industrial resources through 11 production sites in Europe (France, Italy, Spain, the United Kingdom and Switzerland), in Morocco, in the United States, in Brazil and in Australia. Moreover, the Group has a worldwide geographical presence through a dedicated sales network in 16 countries (France, Italy, Spain, the United Kingdom, Belgium, Germany, Switzerland, Russia, U.A.E, Thailand, Singapore, Japan, China, Australia, the United States, Australia).

Naturex's sound performance is linked to the fast-growing demand for natural ingredients and its capacity to provide manufacturers customized solutions with the means to meet the requirements of their end consumers.

Its strength lies in its ability to position itself on specific products which constitute niche markets.

Contacts Naturex

Jacques Dikansky
President and CEO
Tél : +33 (0)4 90 23 96 89

Carole Alexandre
Investor Relations
Tél : +33 (0)4 90 23 78 28
Thierry Lambert
Vice-President and CFO
Tél : +33 (0)4 90 23 96 89

Contacts Actus

Anne Catherine Bonjour
Press Relations
Tél : +33 (0)1 53 67 36 93
Jérôme Fabreguettes-Leib
Investor Relations
Tél : +33 (0)1 77 35 04 36
Information réglementée
Rachat d'actions / contrat de liquidité :
- Information relative au contrat de liquidité Communiqué intégral et original au format PDF : © Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur
Receive by email the next press releases of the company by registering on, it's free

Valeur associée
  Libellé Bourse Dernier Var. Vol.
Vous devez être membre pour ajouter des commentaires.
Devenez membre, ou connectez-vous.
Aucun commentaire n'est disponible pour l'instant